Carboplatin + Paclitaxel (Adjuvant/Palliative Chemotherapy)
Treatment for Uterine cancer
Effectiveness
55%
Safety Score
25%
Clinical Trials
200
Participants
30K
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
25
DangerousModerateSafe
Treatment Details
0
Carboplatin + Paclitaxel (Adjuvant/Palliative Chemotherapy) Outcomes
for Uterine cancer
Efficacy Outcomes
Overall Effectiveness
+55%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov